Sarcoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Above 1 year old, gender is not limited; 2. Patients have been diagnosed or suspected with osteosarcoma, liposarcoma, chondrosarcoma, fibrosarcoma, Ewing's sarcoma family tumors, synovial sarcoma, leiomyosarcoma, and other sarcomas (malignant peripheral neurilemmoma, alveolar soft tissue sarcoma, rhabdomyosarcoma, hyaline cell sarcoma, ligamentous fibroma, etc.); 3. At least one measurable lesion (RECIST v1.1); 4. The score of functional status was more than or equal to 50%. Karnofsky criterion was used for patients over 16 years old and Lansky criterion was used for patients under 16 years old; 5. Subjects volunteered to participate in the study and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. CT/MRI Tumors with unclear margins and no measurable lesions; 2. The patients had multiple primary tumors at the same time; 3. Drug abuse; or any medical, psychological or social condition that may affect research, unstable patient compliance, or even endanger patient safety; 4. Participate in another clinical study that has an impact on the results of this study; 5. In a comprehensive assessment, the researchers did not consider it suitable for the patients who participated in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The guiding Significance of NGS in Pathological Assisted Diagnosis of Sarcoma in China;The gene profiling of major Sarcoma types in Chinese Population; | — |
Countries
China
Contacts
The First Affiliated Hospital, Sun Yat-Sen University